4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-22-004627
Chief Financial Officer bought 10,000 shares at $4.23 ($42,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chardonnet Laurent Chief Financial Officer | 2022-06-01 | Purchase | +10,000 | $4.23 | $42,300 | 24,500 | D |
| Open-market purchases · 10,000 sh · avg $4.23 · $42,300 | |||||||
Loading xslF345X03/primarydocument.xml…